InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Gottesdiener Keith Michael, Director. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 8 filings have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 8 October 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
Gottesdiener Keith Michael serves as a Board Member at INTERCEPT PHARMACEUTICALS, INC. In this role, he contributes to governance and oversight of the company's activities, bringing his expertise in the pharmaceutical sector.